Stock Comparison

NBIX vs TAK

Neurocrine Biosciences Inc and Takeda Pharmaceutical Co Ltd ADR side by side — valuation, profitability, growth and risk.

NBIX

Neurocrine Biosciences Inc

Healthcare

TAK

Takeda Pharmaceutical Co Ltd ADR

Healthcare

Valuation

Market Cap

$16.94B

$50.27B

P/E (TTM)

25.9

—

Forward P/E

23.2

10.3

Price/Sales

5.5

0.0

Price/Book

4.9

1.1

EV/EBITDA

18.8

16.9

Dividend Yield

—

4.16%

Profitability

Net Margin

21.50%

-3.38%

Operating Margin

22.80%

11.10%

Return on Equity

22.50%

-2.12%

Return on Assets

11.60%

2.55%

Growth (YoY)

Revenue Growth

42.20%

3.90%

Earnings Growth

2311.00%

330.20%

Price & Risk

Beta

0.4

0.1

52-Week High

$169.57

$18.90

52-Week Low

$122.14

$12.78

Analyst Target

$194.38

$20.60

Compare NBIX and TAK your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.